Finally out: academic.oup.com/neuro-oncolo...

Please join: www.events-communication.com/event/gliobl...

📸 Throwback Thursday: EANO Seminars 2026 in Bucharest – multidisciplinary, patient-centred neuro-oncology and inspiring exchange across disciplines. Thank you to all contributors for an inspiring exchange! #EANO #NeuroOncology #CNS #EANOSeminars2026 #TBT

🙌 Insightful discussions today in Bucharest at the #EANO Tumor Board 2026. Real-world cases and expert lectures highlighted the importance of multidisciplinary collaboration in improving care for patients with #glioma. Supported by an unrestricted educational grant from Servier. #NeuroOncology

We’re pleased to welcome Martin van den Bent, MD, PhD, as an adjunct professor! In addition to mentoring faculty and residents, he is helping increase UCSF’s role in large international clinical trials: braintumorcenter.ucsf.edu/news/new-neu... @eanoassociation.bsky.social @erasmusmc.bsky.social

The full article “Long-term outcomes of active surveillance after #DOTATATE PET/MRI–confirmed gross total resection in WHO grade 2 #meningioma” is now available. Read the article in #NeuroOncology Advances: bit.ly/4qQR4gn

Read the new article in #NatureMedicine evaluating the efficacy of #abemaciclib, a cyclin-dependent kinase 4/6 inhibitor, for #meningiomas with somatic NF2 or CDK pathway alterations. go.nature.com/4jL77cZ

📣 Join the 4th Annual EANO/SNO Highlights Webinar Top abstracts from #EANO2025 (Prague) & #SNO2025 (Honolulu) – latest advances in neuro-oncology. 🗓 Feb 6, 2026 | ⏰ 18:30–19:30 CET 🎟 Free for #EANO & #SNO members 👉 Register now: bit.ly/EANO-SNO-2025 #NeuroOncology @neuroonc.bsky.social

📃Just published in JNM: our recent study showing the clinical value of FET PET to identify early response to Regorafenib in patients with #glioma. 🔗: jnm.snmjournals.org/content/earl... Thanks to @galldiks.bsky.social, @ph-lohmann.bsky.social and co-authors. #aminoacidPET #braintumor

The joint #ICOM-#BIMS (British Irish Meningioma Society) #meningioma session will be held as part of the 100th Anniversary Meeting of @The_SBNS. Find out more about #SBNS100 here: bit.ly/4pvKifo

#EANO2025 in Prague 🇨🇿 – the highlights. One of our most successful meetings yet: record abstracts, outstanding multidisciplinary science, strong early-career engagement, and for the first time patient representatives. #NeuroOncology. 🎥 youtu.be/CWuMWef_mmI See you in Rome for #EANO2026 🇮🇹

💫 Warm seasonal greetings to our #EANO community! 2025 highlighted the strength and collaboration of #NeuroOncology –made possible by your engagement and support. Wishing you joyful holidays and an inspiring New Year as we look ahead to EANO Seminars and Rome 2026. Übersetzung anzeigen

📣 EANO Seminars 2026 – one week left to apply! The next #EANO seminars will take place in Bucharest, Romania, on March 13–14, 2026. 🗓️ Application deadline: December 10, 2025 👉 Learn more and apply today: www.eano.eu/eanoseminars... #EANO #EANO2026 #NeuroOncology #BrainTumour #CNS

That’s a wrap on WFNOS/SNO 2025 in Honolulu, Hawaii! The #EANO team truly enjoyed connecting with colleagues from around the world, exchanging insights, and celebrating SNO’s 30th anniversary. A big thank you to the @neuroonc.bsky.social for hosting this inspiring meeting! 🌺 #SNO2025 #WFNOS2025

Start of the Educational Day of #SNO2025 and WFNOS2025. Welcoming by @mjlimfat.bsky.social. Looking forward to an inspiring conference in Honolulu. @neuroonc.bsky.social @eanoassociation.bsky.social

Awarded as best clinical science poster at #EANO2025 and now published online: "Clinical potential of [18F]FET PET in patients with circumscribed astrocytic glioma" by @jmwerner.bsky.social and colleagues. 👉 link.springer.com/article/10.1... #NuclearMedicine #Glioma #NeuroOncology #PETImaging

Can DNA methylation risk groups unlock personalized radiotherapy decisions in meningioma? Our new paper provides the clinical framework — thanks to all collaborators! @neuroonc.bsky.social @eanoassociation.bsky.social @gelarehzadeh.bsky.social @icomeningioma.bsky.social doi.org/10.1093/neuo...

Are you a physician, nurse, researcher, technician, or allied health professional with an interest in #NeuroOncology? Join the next #EANO Seminars, taking place in Bucharest, RO, on March 13–14, 2026! - Application deadline: December 10, 2025 - Learn more & apply here: 👉 www.eano.eu/eanoseminars...

Outstanding oral presentation at #EANO2025 in Prague, now published in #NeuroOncology: the Multicenter Randomized Phase II Study of R-MPV-A #Chemoimmunotherapy With or Without Low-Dose Whole-Brain #Radiotherapy for Newly-Diagnosed Primary... by Antonio Omuro & colleagues. 👉 doi.org/10.1093/neuo...

The opening of registrations and abstract submission is just around the corner for the EACR 2026 Annual Congress, so what better time to reflect on our Travel Grant winners' experiences of EACR 2025 that took place earlier this year in Lisbon, Portugal. Read more: magazine.eacr.org/eacr-2025-co...

Exciting times for #EANO! We’re delighted to welcome Roberta Rudà from the University of Turin as President Elect of EANO. Together, we look forward to continuing our mission of advancing science, innovation, and collaboration in #NeuroOncology.

“Long-Term Outcomes of Active Surveillance After DOTATATE PET/MRI–Confirmed Gross Total Resection in WHO Grade 2 #Meningioma” is now available in NOA as an accepted manuscript: academic.oup.com/noa/advance-...

🎗️ EANO proudly supports the 2025 International Brain Tumour Awareness Week! Let’s raise awareness, support patients, and promote advancements in research in #NeuroOncology. Together, we can make a difference! #EANO #BrainTumourAwareness #btsm #BrainTumours

Read the oral abstract poster from August aiming to identify chromosomal copy number alterations which could be used to improve the current CNS WHO grading of meningioma. Read more in @EditorNeuro: bit.ly/4ng5d4m

Read the Cancer Discovery Piece: Rethinking Cancer Drug Development through Tumor-Agnostic Precision Medicine by @viveksubbiah.bsky.social doi.org/10.1158/2159...

Read the letter to the editor ‘PAS+/PASD- intracytoplasmic glycogen is not specific for clear cell #meningioma’ published in the Journal of #Neuropathology & Experimental #Neurology: bit.ly/4986hUr

Congratulations to our #EANO2025 award winners for Best Poster Presentation: @jmwerner.bsky.social (Clinical research), Elisabetta Mori (Basic research), Thomas Millner (Translational research), Jan Coburger (Supportive care and quality of life research)! 👏 #NeuroOncology #EANO

🙌 That’s a wrap on #ESMO25! EORTC shared new results and future trials focused on patient needs, long-term outcomes & treatment optimisation. Thanks to all collaborators and patients who make this work possible. 🔗 Full summary: www.eortc.org/blog/2025/10... #CancerResearch #ClinicalTrials

We had a wonderful #eano2025 in Prague, with multiple talks and poster presentations and fruitful discussions! Looking forward to Rome! @eanoassociation.bsky.social @ghtabatabai.bsky.social @hannes-becker1996.bsky.social @nihalolcaydogan.bsky.social @hih-tuebingen.bsky.social

Read about the first study to comprehensively define the molecular landscape of #meningiomas treated with #Radiotherapy in a prospective clinical trial in #NeuroOncology Advances: bit.ly/4okYUNK

Very grateful for the opportunity to present our results from this international collaboration at #EANO2025! Many thanks to my supervisors, co-authors, and colleagues for all their support! #segmentation #AI #medicalimaging #neurooncology

📢 Today is #WorldStatisticsDay, a moment to reflect on the tools that shape clinical research and medical progress. Do you feel p-values satisfy the needs of clinical research in summarizing proof? 💬 Drop your thoughts in the comments, we’re reading! Know more: www.eortc.org/blog/2025/10...

And he did a fantastic job! Bravo Menno, very proud of you 👏🏻

It was a great pleasure to present our recent work on the spatial dynamics of lipid-laden macrophages at #EANO2025! Many thanks to everyone who attended this great meeting and to @leilaakkari.bsky.social for allowing me to work on this exciting project. @eanoassociation.bsky.social

It’s a wrap! What a fantastic and inspiring #EANO2025. It was great to share projects and ideas. Looking forward to Rome. @winklerlab.bsky.social @hlsalliance.bsky.social @cn-hd.bsky.social @eanoassociation.bsky.social

#EANO2025 was a wonderful, inspiring and truly interdisciplinary meeting - big thanks to the organisers and the warm welcome in Prague 🙏🏻

#EANO2025 wraps up in Prague – thank you to everyone who made this meeting unforgettable! See you in Rome, September 24–27, 2026. 🇮🇹 Save the date for #EANO2026! 🌍 #NeuroOncology #BrainTumours #EANO #btsm

👉 We continue this exciting day at #ESMO25 with a spotlight on patient engagement! Iryna Shakhnenko presents the EORTC framework, shaped by patients and professionals, to boost collaboration and improve research outcomes. 📢 Don't miss it! #Oncology #PatientEngagement #EORTC

#EANO2025 in Prague has come to a close – what an inspiring meeting of science, learning, and collaboration! Thank you to all who contributed to this year’s success. Together we advance #NeuroOncology and improve care for people with brain tumours. #EANO #btsm

#EANO2025 comes to an end - it was a fantastic conference, thanks to everyone who participated and made it possible! See you next year in Rome! @eanoassociation.bsky.social @maxmastall.bsky.social @mj-mair.bsky.social @galldiks.bsky.social @profajchalmers.bsky.social

Thank you for making #EANO2025 such a strong and vibrant community experience! 

🧠 Good morning from #Prague and welcome to the last day of #EANO2025! Let’s wrap up this inspiring meeting with another day of excellent science, lively discussions, and valuable exchange across all areas of #NeuroOncology. Check out today’s highlights 👉 eano.eu/eano2025/pro...

🧠 Bringing #PrecisionOncology to life! 🚀 At #EANO2025, Anna Sophie Berghoff presented the design of the #ATTRACT trial - testing 28 drugs on patient-derived tumor cells to personalize #glioblastoma therapy. 👏 Thanks to @lbg.ac.at & all partners in 🇦🇹! #NeuroOncology #ClinicalTrials #btsm

@glimr-eu.bsky.social is at #EANO2025 in beautiful Prague!

👏 Well done to Denis Lacombe for a compelling session today at #ESMO25! Together, we’re shaping a future of cancer research that’s smarter and more inclusive. #EORTC #CancerResearch #DEI #ClinicalTrials @myesmo.bsky.social

The final day of #EANO2025 starts with the general assembly! Wonderful to see how well each committee is doing, thank you very much! @eanoassociation.bsky.social @galldiks.bsky.social @mj-mair.bsky.social @maxmastall.bsky.social @profajchalmers.bsky.social @jmwerner.bsky.social

Lively debates and sharp arguments at the #EANO2025 Youngsters Pro&Con Session - informative, entertaining, and full of expert insights, this is what scientific exchange should look like! #NeuroOncology @eanoassociation.bsky.social @maxmastall.bsky.social @galldiks.bsky.social

Now Surender Surender on stage, presenting our data on CDK4/6 inhibition in experimental glioma! @eanoassociation.bsky.social @ghtabatabai.bsky.social @hih-tuebingen.bsky.social